{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:00:56Z","timestamp":1789563656056,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI114685"],"award-info":[{"award-number":["R01AI114685"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministerio de Econom\u00eda, Industria y Competitividad","award":["SAF2015-71444-P"],"award-info":[{"award-number":["SAF2015-71444-P"]}]},{"name":"Spanish Ministerio de Econom\u00eda, Industria y Competitividad","award":["SAF2015-68042-R"],"award-info":[{"award-number":["SAF2015-68042-R"]}]},{"name":"Spanish Ministerio de Econom\u00eda, Industria y Competitividad","award":["SAF2016-79957-R"],"award-info":[{"award-number":["SAF2016-79957-R"]}]},{"name":"Junta de Andaluc\u00eda","award":["CTS-7282"],"award-info":[{"award-number":["CTS-7282"]}]},{"name":"Subdirecci\u00f3n General de Redes y Centros de Investigaci\u00f3n Cooperativa"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bmcl.2017.07.032","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T16:02:13Z","timestamp":1499788933000},"page":"3629-3635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei"],"prefix":"10.1016","volume":"27","author":[{"given":"ThanhTruc","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Walden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Diaz-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiomar","family":"P\u00e9rez-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Ceballos-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Gomez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Zecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Krakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kopec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogar","family":"Ichire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caden","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Pitot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Miguel","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gamarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Gonz\u00e1lez-Pacanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2301-2699","authenticated-orcid":false,"given":"Miguel","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B.","family":"Dounay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2017.07.032_b0005","unstructured":"World Health Organization. Trypanosomiasis, Human African (Sleeping Sickness). <http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/>; Accessed 28.04.17."},{"key":"10.1016\/j.bmcl.2017.07.032_b0010","doi-asserted-by":"crossref","first-page":"e1695","DOI":"10.1371\/journal.pntd.0001695","article-title":"Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage rhodesiense sleeping sickness","volume":"6","author":"Kuepfer","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmcl.2017.07.032_b0015","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1086\/429929","article-title":"Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (Impamel II)","volume":"191","author":"Schmid","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2017.07.032_b0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmcl.2017.07.032_b0025","unstructured":"World Health Organization. Human African Trypanosomiasis: Research. http:\/\/www.who.int\/trypanosomiasis_african\/research\/en\/; Accessed 28.04.17."},{"key":"10.1016\/j.bmcl.2017.07.032_b0030","first-page":"1","article-title":"Human African trypanosomiasis: what are the prospects for control?","volume":"9","author":"Gjini","year":"2017","journal-title":"Hum Parasitic Dis"},{"key":"10.1016\/j.bmcl.2017.07.032_b0035","doi-asserted-by":"crossref","first-page":"e3253","DOI":"10.1371\/journal.pntd.0003253","article-title":"Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign","volume":"8","author":"Diaz","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmcl.2017.07.032_b0040","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/cn100007x","article-title":"Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmcl.2017.07.032_b0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cn100008c","article-title":"Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of drug like properties","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmcl.2017.07.032_b0050","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/jm060642i","article-title":"Structure\u2013brain exposure relationships","volume":"49","author":"Hitchcock","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.07.032_b0055","unstructured":"LE=1.4(\u2212logEC50)\/#Heavy atoms)."},{"key":"10.1016\/j.bmcl.2017.07.032_b0060","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","article-title":"Ligand efficiency: a useful metric for lead selection","volume":"9","author":"Hopkins","year":"2004","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.bmcl.2017.07.032_b0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2017.07.032_b0070","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/S0040-4020(01)87338-5","article-title":"Synthesis of quinazolines","volume":"42","author":"Bergman","year":"1986","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2017.07.032_b0075","unstructured":"Suzuki coupling protocol was adapted from Adams ND, Darcy MG, Dhanak D, et al. PCT Int. Appl. 2006; WO 2006113432."},{"key":"10.1016\/j.bmcl.2017.07.032_b0080","series-title":"Lead Generation Approaches in Drug Discovery","first-page":"21","article-title":"High throughput screening approach to lead discovery","author":"Rankovic","year":"2010"},{"key":"10.1016\/j.bmcl.2017.07.032_b0085","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.drudis.2009.09.004","article-title":"HTS and hit finding in academia \u2013 from chemical genomics to drug discovery","volume":"14","author":"Frearson","year":"2009","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.bmcl.2017.07.032_b0090","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1021\/jm5019093","article-title":"PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS","volume":"58","author":"Dahlin","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.07.032_b0095","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0022-3565(25)39248-7","article-title":"Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine","volume":"243","author":"Kaul","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2017.07.032_b0100","first-page":"380","article-title":"Role of physicochemical properties and ligand lipophilicity efficiency in addressing drug safety risks","volume":"Vol. 45","author":"Edwards","year":"2010"},{"key":"10.1016\/j.bmcl.2017.07.032_b0105","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1021\/jm100118x","article-title":"An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs","volume":"53","author":"Perola","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.07.032_b0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd3367","article-title":"Probing the links between in vitro potency, ADMET and physicochemical parameters","volume":"10","author":"Gleeson","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2017.07.032_b0115","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.bmcl.2008.07.071","article-title":"Physiochemical drug properties associated with in vivo toxicological outcomes","volume":"18","author":"Hughes","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.07.032_b0120","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1016\/j.bmcl.2009.08.045","article-title":"Using the golden triangle to optimize clearance and oral absorption","volume":"19","author":"Johnson","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.07.032_b0125","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1016\/j.bmcl.2009.03.109","article-title":"Defining optimum lipophilicity and molecular weight ranges for drug candidates\u2014molecular weight dependent lower Log D limits based on permeability","volume":"19","author":"Waring","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.07.032_b0130","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.bmcl.2006.12.061","article-title":"Quantitative assessment of hERG liability as a function of lipophilicity","volume":"17","author":"Waring","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2017.07.032_b0135","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.07.032_b0140","doi-asserted-by":"crossref","first-page":"11280","DOI":"10.1021\/cr500197d","article-title":"Kinases as druggable targets in trypanosomatid protozoan parasites","volume":"114","author":"Merritt","year":"2014","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2017.07.032_b0145","unstructured":"Calculator Plugins were used for cLogP calculation, ChemAxon (http:\/\/www.chemaxon.com)."}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X1730728X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X1730728X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:19:24Z","timestamp":1760771964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X1730728X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":29,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0960894X1730728X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.07.032","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}